-
Mashup Score: 8
The IAS Global HIV Vaccine Enterprise is pleased to invite you to a webinar, “Experimental Medicine Trials for HIV Vaccine Research”. In this second webinar in a 2-part series we will look into planned and ongoing experimental medicine trials for the development of HIV vaccines. Strategies, products, and trial designs will be reviewed and discussed with the aim to identify the most promising…
Source: Zoom Video CommunicationsCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 5AAVCOVID vaccine: A combination of factors harnessing COVID-19 - 3 year(s) ago
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
AAVCOVID vaccine: A combination of factors harnessing #COVID19: https://t.co/ViCaMa6tXo #Ophthalmology #Vacccine #GeneTherapy #CellTherapy https://t.co/j1z2bxyHk6
-
-
Mashup Score: 3AAVCOVID vaccine: A combination of factors harnessing COVID-19 - 3 year(s) ago
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
AAVCOVID vaccine: A combination of factors harnessing #COVID19: https://t.co/ngw1hl1sbm #Ophthalmology #Vacccine #GeneTherapy #CellTherapy https://t.co/QL2TGiEsig
-
-
Mashup Score: 3AAVCOVID vaccine: A combination of factors harnessing COVID-19 - 3 year(s) ago
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
AAVCOVID vaccine: A combination of factors harnessing #COVID19: https://t.co/ePUpvoVQiH #Ophthalmology #Vacccine #GeneTherapy #CellTherapy https://t.co/KX1r9QcwSM
-
-
Mashup Score: 2AAVCOVID vaccine: A combination of factors harnessing COVID-19 - 3 year(s) ago
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
AAVCOVID vaccine: A combination of factors harnessing #COVID19: https://t.co/8HE5i9oqE0 #Ophthalmology #Vacccine #GeneTherapy #CellTherapy https://t.co/W9CQdJ9t7R
-
-
Mashup Score: 2AAVCOVID vaccine: A combination of factors harnessing COVID-19 - 3 year(s) ago
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
AAVCOVID vaccine: A combination of factors harnessing #COVID19: https://t.co/JHBNL7iHGW #Ophthalmology #Vacccine #GeneTherapy #CellTherapy https://t.co/E0zWLPGyO7
-
-
Mashup Score: 7AAVCOVID vaccine: A combination of factors harnessing COVID-19 - 3 year(s) ago
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
AAVCOVID vaccine: A combination of factors harnessing #COVID19: https://t.co/ZB4dUDCDbP #Ophthalmology #Vacccine #GeneTherapy #CellTherapy https://t.co/bXR4Qo8z7S
-
-
Mashup Score: 2AAVCOVID vaccine: A combination of factors harnessing COVID-19 - 3 year(s) ago
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
AAVCOVID vaccine: A combination of factors harnessing #COVID19: https://t.co/A5N4h3gUTU #Ophthalmology #Vacccine #GeneTherapy #CellTherapy https://t.co/B3PCJ11pnz
-
-
Mashup Score: 2
In response to the SARS-CoV-2 pandemic, we are currently witnessing the fastest vaccine development in history. While these vaccines will now make a significant impact on ending the pandemic, they were needed much earlier. Here I discuss how to ensure that vaccines will become available within 3-4 months after a new outbreak.
Source: MedCategories: General Medicine News, Latest HeadlinesTweet-
"Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?" - A @MedCellPress Commentary by @IcahnMountSinai @florian_krammer https://t.co/y5cvczosvD #pandemic #vacccine #covid19 #med https://t.co/WKAxvvB5GD
-
-
Mashup Score: 3
In response to the SARS-CoV-2 pandemic, we are currently witnessing the fastest vaccine development in history. While these vaccines will now make a significant impact on ending the pandemic, they were needed much earlier. Here I discuss how to ensure that vaccines will become available within 3-4 months after a new outbreak.
Source: MedCategories: General Medicine News, Latest HeadlinesTweet-
"Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?" - A @MedCellPress Commentary by @IcahnMountSinai @florian_krammer https://t.co/asLhCSPAZq #pandemic #vacccine #covid19 #med https://t.co/wk9vCnuZqh
-
Heard the latest news about the development of an #HIV #vacccine? Want to learn more? Join us in exactly 1 hour for a free #webinar that will feature leading experts exploring the most promising areas for vaccine development. Register now! https://t.co/j9urA4sZw3 https://t.co/sbq4cTnenE